ABBV - AbbVie - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ABBV is currently covered by 23 analysts with an average price target of $226.26. This is a potential upside of $27.4 (13.78%) from yesterday's end of day stock price of $198.86.

AbbVie's activity chart (see below) currently has 416 price targets and 356 ratings on display. The stock rating distribution of ABBV is 83.95% BUY and 16.05% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 92.44% with an average time for these price targets to be met of 485.82 days.

Highest price target for ABBV is $250, Lowest price target is $181, average price target is $208.48.

Most recent stock forecast was given by GEOFF MEACHAM from CITI on 14-May-2025.

Currently out of the existing stock ratings of ABBV, 68 are a BUY (83.95%), 13 are a HOLD (16.05%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$205

$6.14 (3.09%)

$215

2 months 28 days ago
(14-May-2025)

12/14 (85.71%)

$27.59 (15.55%)

285

Buy

$216

$17.14 (8.62%)

$214

3 months 13 days ago
(29-Apr-2025)

23/26 (88.46%)

$22.49 (11.62%)

431

Buy

$250

$51.14 (25.72%)

$241

3 months 14 days ago
(28-Apr-2025)

12/18 (66.67%)

$57.66 (29.98%)

526

Buy

$240

$41.14 (20.69%)

$210

5 months 6 days ago
(05-Mar-2025)

7/8 (87.5%)

$28.46 (13.45%)

474

Hold

$223

$24.14 (12.14%)

$191

5 months 7 days ago
(04-Mar-2025)

3/4 (75%)

$15.71 (7.58%)

443

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ABBV (AbbVie) average time for price targets to be met?

On average it took 485.82 days on average for the stock forecasts to be realized with a an average price target met ratio 92.44

Which analyst has the current highest performing score on ABBV (AbbVie) with a proven track record?

JOHN BORIS

Which analyst has the most public recommendations on ABBV (AbbVie)?

John Boris has 1 price targets and 1 ratings on ABBV

Which analyst is the currently most bullish on ABBV (AbbVie)?

Terence Flynn with highest potential upside - $51.14

Which analyst is the currently most reserved on ABBV (AbbVie)?

Alex Arfaei with lowest potential downside - -$119.86

AbbVie in the News

SA Asks: How could Trump's drug pricing demands impact stocks?

[Pile of Prescription Pills and Bottles] Bjarte Rettedal Last week, President Trump sent letters to 17 major pharmaceutical companies advising them to work with his administration to lower drug prices within the next 60 days or face significant penalties. The letters were sent to the CEOs [https://truthsocial.com/@realDonaldTrump?gsid=e04f7688-ddc6-4d70-b4d5-a46c2a8ba7ae] of AbbVie (NYSE:ABBV [https://seekingalpha.com/symbol/ABBV]), Amgen (NASDAQ:AMGN [https://seekingalpha.com/symbol/AMGN]), AstraZeneca...

Trump administration reportedly seeks higher ex-US drug prices in pursuit of MFN policy

[The White House in Washington DC] lucky-photographer The U.S. government has been discussing with drugmakers how to raise overseas drug prices as President Donald Trump seeks to implement his Most Favored Nation policy, which attempts to lower U.S. drug prices to the level of other wealthy nations, Reuters reported. Citing a White House official, the...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?